Lee Danner & Bass Inc Abbott Laboratories Transaction History

Lee Danner & Bass Inc

  • $1.42 Billion
  • Q3 2024

A detailed history of Lee Danner & Bass Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Lee Danner & Bass Inc holds 35,673 shares of ABT stock, worth $4.2 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
35,673
Previous 35,673 -0.0%
Holding current value
$4.2 Million
Previous $3.71 Million 9.71%
% of portfolio
0.29%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$100.73 - $112.44 $5,338 - $5,959
-53 Reduced 0.15%
35,673 $3.71 Million
Q4 2023

Feb 01, 2024
SELL
$90.19 - $110.4 $30,664 - $37,536
-340 Reduced 0.94%
35,726 $3.93 Million
Q3 2023

Oct 27, 2023
BUY
$95.53 - $114.62 $80,818 - $96,968
846 Added 2.4%
36,066 $3.49 Million
Q2 2023

Jul 31, 2023
SELL
$100.78 - $112.29 $15,923 - $17,741
-158 Reduced 0.45%
35,220 $3.84 Million
Q1 2023

May 02, 2023
SELL
$96.86 - $114.01 $5,230 - $6,156
-54 Reduced 0.15%
35,378 $3.58 Million
Q4 2022

Feb 01, 2023
SELL
$95.06 - $111.52 $15,875 - $18,623
-167 Reduced 0.47%
35,432 $3.89 Million
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $21,093 - $24,422
-218 Reduced 0.61%
35,599 $3.45 Million
Q2 2022

Jul 25, 2022
BUY
$102.07 - $123.37 $50,830 - $61,438
498 Added 1.41%
35,817 $3.89 Million
Q1 2022

Apr 27, 2022
SELL
$114.02 - $139.04 $7,981 - $9,732
-70 Reduced 0.2%
35,319 $4.18 Million
Q4 2021

Jan 27, 2022
SELL
$115.53 - $141.46 $6,931 - $8,487
-60 Reduced 0.17%
35,389 $4.98 Million
Q3 2021

Nov 01, 2021
SELL
$116.66 - $129.06 $325,948 - $360,593
-2,794 Reduced 7.31%
35,449 $4.19 Million
Q2 2021

Jul 27, 2021
SELL
$105.79 - $124.53 $127,371 - $149,934
-1,204 Reduced 3.05%
38,243 $4.43 Million
Q1 2021

Apr 29, 2021
SELL
$108.84 - $128.23 $30,257 - $35,647
-278 Reduced 0.7%
39,447 $4.73 Million
Q4 2020

Feb 09, 2021
SELL
$105.0 - $114.42 $288,855 - $314,769
-2,751 Reduced 6.48%
39,725 $4.35 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $372,516 - $452,393
-4,065 Reduced 8.73%
42,476 $4.62 Million
Q2 2020

Aug 10, 2020
SELL
$76.57 - $98.0 $306,892 - $392,784
-4,008 Reduced 7.93%
46,541 $4.26 Million
Q1 2020

May 04, 2020
SELL
$62.82 - $91.86 $39,513 - $57,779
-629 Reduced 1.23%
50,549 $3.99 Million
Q4 2019

Feb 13, 2020
SELL
$78.51 - $87.4 $126,322 - $140,626
-1,609 Reduced 3.05%
51,178 $4.45 Million
Q3 2019

Oct 30, 2019
SELL
$81.84 - $88.74 $91,087 - $98,767
-1,113 Reduced 2.06%
52,787 $4.42 Million
Q2 2019

Jul 30, 2019
SELL
$72.88 - $85.0 $105,603 - $123,165
-1,449 Reduced 2.62%
53,900 $4.53 Million
Q1 2019

May 06, 2019
SELL
$66.22 - $80.06 $104,230 - $126,014
-1,574 Reduced 2.77%
55,349 $4.43 Million
Q4 2018

Jan 29, 2019
SELL
$65.56 - $74.27 $50,415 - $57,113
-769 Reduced 1.33%
56,923 $4.12 Million
Q3 2018

Nov 06, 2018
SELL
$60.81 - $73.36 $21,952 - $26,482
-361 Reduced 0.62%
57,692 $4.23 Million
Q2 2018

Nov 02, 2018
BUY
$57.57 - $63.54 $1,439 - $1,588
25 Added 0.04%
58,053 $3.54 Million
Q2 2018

Aug 06, 2018
SELL
$57.57 - $63.54 $21,416 - $23,636
-372 Reduced 0.64%
58,028 $3.8 Million
Q1 2018

May 02, 2018
SELL
$56.27 - $63.62 $47,773 - $54,013
-849 Reduced 1.43%
58,400 $3.5 Million
Q4 2017

Feb 02, 2018
SELL
$53.68 - $57.47 $32,369 - $34,654
-603 Reduced 1.01%
59,249 $3.38 Million
Q3 2017

Oct 27, 2017
BUY
$48.06 - $53.64 $2.88 Million - $3.21 Million
59,852
59,852 $3.19 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email